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Abstract 
Progressive remodeling of the left ventricle (LV) following myocardial infarction (MI) 
involves spatiotemporal interactions among multiple cell types and the extracellular matrix 
environment. Despite the extensive experimental studies designed to elucidate the 
regulatory mechanisms, there is a growing recognition that the complexity of LV 
remodeling precludes the efficient identification of early diagnostic indicators after 
myocardial infarction. Currently, systemic approaches are needed to reduce this complexity. 
Previous studies in other systems demonstrate that establishing a multi-scale analytical 
model of LV remodeling response to MI will likely help in the development of prognostic 
therapies. In this review, we discuss the current approaches used for mathematical 
modeling of the LV, advantages and disadvantages of the approaches, and methods used to 
validate these models.  
Keywords: mathematical model, left ventricular remodeling, extracellular matrix, 
inflammation, outcome prediction, model validation 
 
1. Introduction 
A myocardial infarction (MI) occurs when a coronary artery becomes totally closed off, 
resulting in the loss of oxygen to the downstream myocardium (a process termed ischemia).  
Following MI, the left ventricle (LV) undergoes a spectrum of responses at the gene and 
protein levels that are represented clinically as changes in LV size, shape, and function [1]. 
LV remodeling encompasses many alterations, including LV wall thinning, LV dilation, and 
infarct expansion; inflammation and necrotic myocyte resorption; fibroblast accumulation 
and scar formation; and endothelial cell activation and neovascularization [2, 3].  LV 
remodeling is also influenced by variations in leukocyte response (neutrophil and 
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macrophage influx), blood pressure and volume, molecular changes (neurohormonal 
activation and cytokine production), and extracellular matrix responses (fibrosis and 
activation of proteases, particularly the matrix metalloproteinases (MMPs) and serine 
proteases) [4].  In addition, pre-existing conditions such as increased age, diabetes, or the 
use of drugs such as angiotensin converting enzyme inhibitors and  adrenergic receptor 
inhibitors can influence remodeling outcomes.  Basically, LV remodeling after MI is a 
complex wound healing response that involves the dynamic spatiotemporal interactions 
between the various cell types and the acellular components. 
 
2. Rationale for Mathematical Modeling of LV Remodeling 
While research over the past 30 years has accumulated vast amounts of experimental data 
and has greatly improved our understanding of LV remodeling post-MI, this knowledge has 
not been translated to the effective identification of early diagnostic indicators that can 
accurately predict the post-MI patient who is at high risk to develop heart failure. This is 
evidenced by the fact that long-term heart failure survival post-MI has not been improved, 
and a five year mortality rate of 50% persists [5]. MI is the number one cause of heart failure, 
accounting for 70% of all heart failure cases [6].   Therefore, using mathematical modeling 
approaches to understand how the LV progresses during the post-MI response may provide 
mechanistic insight into LV remodeling that can be used to develop novel therapeutic 
strategies. 
The complexity of LV remodeling and the inability of one experiment to all-inclusively 
examine all parameters (or even examine only the most critical parameters) make it 
impossible to experimentally study this problem at the whole systems level.  What is needed 
is to separate the system into its constituent parts and recombine these parts together to 
understand the whole system.  
This superposition approach is successful if the system is linear and the tested variables are 
independent from each other. LV remodeling, however, involves many components with 
coupled feedback loops and nonlinear saturating kinetic responses. The remodeling process 
exhibits “emergent behavior”, which means that remodeling displays system dynamics that 
are not attributable to any specific component but rather to the whole system.  Therefore, 
analyzing individual components in isolation is not likely to reveal the full spectrum of 
system behavior. Indeed, there is growing recognition that complex biological progression 
should be examined based on spatiotemporal interactions [7-14].  Spatiotemporal 
interactions can be characterized in terms of mathematical relations built on the mechanism 
of the system and validated by experimental data. In particular, the availability of high-
throughput quantitative data and improved computing power have recently made 
mathematical modeling of LV remodeling more feasible.  
In this review, we will focus on the temporal profiles of biochemical components in the LV 
post-MI in mice, current mathematical modeling methods that can be used to develop 
models, and methods to validate the mathematical model with experimental data.  
 
3. Temporal Profiles of LV remodeling 
MI occurs when there is a sustained interruption of the blood supply to the heart, leading to 
rapid death of the myocytes in the affected part of the cardiac wall.  Since cardiac myocytes 
are post-mitotic cells, the necrotic myocytes cannot be replaced with cells with similar 
characteristics, as occurs in other wound healing systems such as the skin and liver.  Instead, 
the infarct area is repaired with granulation tissue that matures into a scar.  Progressive LV 
remodeling post-MI can be divided into four phases: the necrotic phase immediately after 
MI, the acute inflammatory response phase from day 1-7, the formation of granulation tissue 
phase (1-3 weeks), and the remodeling phase (> 3 weeks) [15, 16].  
 
3.1 Cellular changes 
In normal mouse myocardium, the Baudino laboratory has shown that myocytes, 
fibroblasts, vascular smooth muscle cells, and endothelial cells accounts for 56%, 27%, 10%, 
and 7% of total cell numbers, respectively [17]. Post MI, myocytes die and the major cell 
types are (myo)fibroblasts, endothelial cells, and inflammatory cells (including neutrophils, 
macrophages, and lymphocytes). 
 
Necrotic phase: myocytes  
As early as six hours post-MI, myocyte death is apparent. Apoptosis is believed to be 
responsible for the early myocyte death in the first 6 hrs to 8 hrs post-MI, whereas necrosis is  
more of a secondary event that occur 12 hrs to 4 days after myocardial infarction [18]. This 
secondary event may be caused by the fact that the majority of apoptotic cells cannot be 
consumed or phagocytosed by neighboring cells.  In reaction to this, an inflammatory 
response is initiated within the infarct region.  The influx of leukocytes is the hallmark of the 
inflammatory response phase. 
 
Inflammatory response phase: neutrophils, macrophages, and lymphocytes 
The early inflammatory response after myocardial infarction takes place within 12 - 16 hours 
after the onset of ischemia (in the absence of reperfusion). Neutrophils are the first immune 
response cells to arrive at a site of infection.  Neutrophils produce enzymes such as elastase 
and matrix metalloproteinase (MMPs) that allow inflammatory cells to migrate into the 
infarct tissue to remove the necrotic myocytes.  The number of neutrophils migrated to the 
infarct region peaks at 1-3 days after MI and is significantly declined by day 5 post-MI [19].  
After releasing storage granule components, neutrophils undergo apoptosis and are 
subsequently removed by macrophages.   
Macrophages follow the neutrophils influx and have a strong phagocytic function to remove 
necrotic myocytes and apoptotic neutrophils. Activated macrophages are differentiated 
from peripheral blood monocytes [21]. Macrophage proliferation is not a significant 
component, since previous studies have shown that <5% of macrophages undergo mitotic 
division [20, 21]. Macrophages infiltrate into the infarct from days 2-7 and peak at day 4 , 
indicating that the acute inflammatory response occurs within 4 days and is marked by the 
removal of necrotic tissue and repair. Macrophage infiltration gradually decreases after day 
14, even though macrophage densities are still higher than control at day 28 post-MI [19].  
Macrophages do not die locally in the scar tissue but emigrate to the lymph node system for 
disposal [22]. Macrophages play a pivotal role in the transition between inflammation 
response and fibrotic phase stimulated by macrophage secretory product, transforming 
growth factor  (TGF-).  
Lymphocyte infiltration peaks at 1 week post-MI and gradually decreases, suggesting that 
the transformation from an acute to chronic inflammation begins within 1 week. Of these 
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macrophage influx), blood pressure and volume, molecular changes (neurohormonal 
activation and cytokine production), and extracellular matrix responses (fibrosis and 
activation of proteases, particularly the matrix metalloproteinases (MMPs) and serine 
proteases) [4].  In addition, pre-existing conditions such as increased age, diabetes, or the 
use of drugs such as angiotensin converting enzyme inhibitors and  adrenergic receptor 
inhibitors can influence remodeling outcomes.  Basically, LV remodeling after MI is a 
complex wound healing response that involves the dynamic spatiotemporal interactions 
between the various cell types and the acellular components. 
 
2. Rationale for Mathematical Modeling of LV Remodeling 
While research over the past 30 years has accumulated vast amounts of experimental data 
and has greatly improved our understanding of LV remodeling post-MI, this knowledge has 
not been translated to the effective identification of early diagnostic indicators that can 
accurately predict the post-MI patient who is at high risk to develop heart failure. This is 
evidenced by the fact that long-term heart failure survival post-MI has not been improved, 
and a five year mortality rate of 50% persists [5]. MI is the number one cause of heart failure, 
accounting for 70% of all heart failure cases [6].   Therefore, using mathematical modeling 
approaches to understand how the LV progresses during the post-MI response may provide 
mechanistic insight into LV remodeling that can be used to develop novel therapeutic 
strategies. 
The complexity of LV remodeling and the inability of one experiment to all-inclusively 
examine all parameters (or even examine only the most critical parameters) make it 
impossible to experimentally study this problem at the whole systems level.  What is needed 
is to separate the system into its constituent parts and recombine these parts together to 
understand the whole system.  
This superposition approach is successful if the system is linear and the tested variables are 
independent from each other. LV remodeling, however, involves many components with 
coupled feedback loops and nonlinear saturating kinetic responses. The remodeling process 
exhibits “emergent behavior”, which means that remodeling displays system dynamics that 
are not attributable to any specific component but rather to the whole system.  Therefore, 
analyzing individual components in isolation is not likely to reveal the full spectrum of 
system behavior. Indeed, there is growing recognition that complex biological progression 
should be examined based on spatiotemporal interactions [7-14].  Spatiotemporal 
interactions can be characterized in terms of mathematical relations built on the mechanism 
of the system and validated by experimental data. In particular, the availability of high-
throughput quantitative data and improved computing power have recently made 
mathematical modeling of LV remodeling more feasible.  
In this review, we will focus on the temporal profiles of biochemical components in the LV 
post-MI in mice, current mathematical modeling methods that can be used to develop 
models, and methods to validate the mathematical model with experimental data.  
 
3. Temporal Profiles of LV remodeling 
MI occurs when there is a sustained interruption of the blood supply to the heart, leading to 
rapid death of the myocytes in the affected part of the cardiac wall.  Since cardiac myocytes 
are post-mitotic cells, the necrotic myocytes cannot be replaced with cells with similar 
characteristics, as occurs in other wound healing systems such as the skin and liver.  Instead, 
the infarct area is repaired with granulation tissue that matures into a scar.  Progressive LV 
remodeling post-MI can be divided into four phases: the necrotic phase immediately after 
MI, the acute inflammatory response phase from day 1-7, the formation of granulation tissue 
phase (1-3 weeks), and the remodeling phase (> 3 weeks) [15, 16].  
 
3.1 Cellular changes 
In normal mouse myocardium, the Baudino laboratory has shown that myocytes, 
fibroblasts, vascular smooth muscle cells, and endothelial cells accounts for 56%, 27%, 10%, 
and 7% of total cell numbers, respectively [17]. Post MI, myocytes die and the major cell 
types are (myo)fibroblasts, endothelial cells, and inflammatory cells (including neutrophils, 
macrophages, and lymphocytes). 
 
Necrotic phase: myocytes  
As early as six hours post-MI, myocyte death is apparent. Apoptosis is believed to be 
responsible for the early myocyte death in the first 6 hrs to 8 hrs post-MI, whereas necrosis is  
more of a secondary event that occur 12 hrs to 4 days after myocardial infarction [18]. This 
secondary event may be caused by the fact that the majority of apoptotic cells cannot be 
consumed or phagocytosed by neighboring cells.  In reaction to this, an inflammatory 
response is initiated within the infarct region.  The influx of leukocytes is the hallmark of the 
inflammatory response phase. 
 
Inflammatory response phase: neutrophils, macrophages, and lymphocytes 
The early inflammatory response after myocardial infarction takes place within 12 - 16 hours 
after the onset of ischemia (in the absence of reperfusion). Neutrophils are the first immune 
response cells to arrive at a site of infection.  Neutrophils produce enzymes such as elastase 
and matrix metalloproteinase (MMPs) that allow inflammatory cells to migrate into the 
infarct tissue to remove the necrotic myocytes.  The number of neutrophils migrated to the 
infarct region peaks at 1-3 days after MI and is significantly declined by day 5 post-MI [19].  
After releasing storage granule components, neutrophils undergo apoptosis and are 
subsequently removed by macrophages.   
Macrophages follow the neutrophils influx and have a strong phagocytic function to remove 
necrotic myocytes and apoptotic neutrophils. Activated macrophages are differentiated 
from peripheral blood monocytes [21]. Macrophage proliferation is not a significant 
component, since previous studies have shown that <5% of macrophages undergo mitotic 
division [20, 21]. Macrophages infiltrate into the infarct from days 2-7 and peak at day 4 , 
indicating that the acute inflammatory response occurs within 4 days and is marked by the 
removal of necrotic tissue and repair. Macrophage infiltration gradually decreases after day 
14, even though macrophage densities are still higher than control at day 28 post-MI [19].  
Macrophages do not die locally in the scar tissue but emigrate to the lymph node system for 
disposal [22]. Macrophages play a pivotal role in the transition between inflammation 
response and fibrotic phase stimulated by macrophage secretory product, transforming 
growth factor  (TGF-).  
Lymphocyte infiltration peaks at 1 week post-MI and gradually decreases, suggesting that 
the transformation from an acute to chronic inflammation begins within 1 week. Of these 
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three leukocyte cell types, the lymphocyte is the least understood in terms of post-MI 
responses. 
 
Formation of granulation tissue phase: fibroblasts 
Two to 3 days post-MI, the granulation tissue begins to form around the border of the 
infarct region.  This tissue is rich in inflammatory cells, fibroblasts, and blood vessels.[16]  
During this phase, fibroblasts start ECM deposition, which increases the myocardial tensile 
strength. Myofibroblasts first appear in the infarct at day 3 and remain at high levels 
through day 28 post-MI. The major source of fibroblasts is the resident cell [23] and the 
circulating fibrocyte  is a minor source. Previous study has shown that proliferation rate of 
fibroblasts in C57BL/6J mice was 15.4±1.1% 4 days post-MI, declined to 4.1±0.6% by 1 week, 
progressively slowed to 0.2±0.6% after 2 weeks, and 0.03±0.1% after 4 weeks [24]. Our lab 
also demonstrated that fibroblast proliferation rates decrease by day 28 post-MI, indicating 
that fibroblast densities may reach a saturation point. It has also been shown that 
myofibroblasts replicated at the border of the infarct zone migratE inward at day 4, more 
centrally at one week, sporadically at 2 weeks, and ceased by 4 weeks [24, 25]. In addition, 
our previous studies have shown that fibroblast growth rate, secretion rate, and migration 
are modulated by TGF-.   
 
Remodeling phase: myofibroblasts 
Approaching 3 weeks post-MI, the cell number in the granulation tissue starts to decrease.  
This is the first hallmark of the remodeling phase of infarct wound healing.  Apoptosis plays 
an important role in the decreasing cell numbers.  However, a unique feature of the cardiac 
scar, compared with skin scars, is the persistent presence of fibroblasts.  Fibroblasts have 
been visualized in human post-MI scars as late as 17 years after the MI.  This implies that 
fibroblasts in the cardiac scar are crucial mediators of remodeling and may be less prone to 
apoptosis than in other types of scars.   
 
 
Angiogenesis:  endothelial cells  
Angiogenesis is the process of generating new capillary blood vessels, which restores blood 
supply to the heart.  The angiogenesis phase overlaps with the inflammatory and 
granulation tissue phases, and improves cell survival during these phases. Activation and 
proliferation of endothelial cells are essential steps in angiogenesis. It has been shown that 
continuous endothelial cell activation increases angiogenesis [26]. Virag and colleagues have 
shown that proliferation rates of endothelial cell in C57BL/6J mice are 2.9±0.5% at 4 days 
post-MI, decline to 0.7±0.1% by 1 week, and remain at low levels of 0.2±0.1% after 2 weeks 
and 0.4±0.3% after 4 weeks [24]. Endothelial cells, therefore, are important contributors to 
post-MI remodeling.   
 
3.2 Cytokine and Growth Factor changes post-MI 
Multiple cytokines have been measured at the gene and protein levels.  IL-1 levels increase 
within 3 hours, remain high at 6-12 hours, and decrease by 24 hours post-MI in C57/BL6J 
mice [27]. TNF- levels are elevated on days 1 and 2, significantly decline by day 7, and 
gradually decrease to baseline levels by day 28. IL-6 shares a similar temporal profile with 
TNF- [28]. IL-10 is elevated on day 1, peaks on day 2 and shows sustained increases at day 
7, and declines significantly on day 28. TGF-1 mRNA expression significantly increases at 
day 3 and gradually decreases from days 7 to 28, even though their expression levels are still 
higher than controls [29]. In addition, Schnoor and colleagues have recently demonstrated 
that macrophages contain mRNAs for a large number of collagens (particularly collagen VI) 
and fibronectin [30]. 
 
3.3 ECM changes 
The cardiac extracellular matrix (ECM) provides the environment for cell migration, 
proliferation, adhesion, and cell-to-cell signaling. Cardiac ECM includes collagens (types I, III, 
IV, V, and VI); matricellular proteins (tenascins, thrombospondins, and secreted protein acidic 
and rich in cysteine); proteoglycans (lumican, versican, and biglycan); glycosaminoglycans 
(hyaluronic acid and dermatan sulfate); and glycoproteins (fibronectin, laminins, periostin, 
fibromodulin, and vitronectin) [31].  Extracellular proteases include serine proteases and 
MMPs that are present either bound to the ECM, in various cell types, or in circulating blood. 
In addition, the development of LV remodeling has been linked to the discontinuity and 
disruption of the supporting collagen network within in the ECM [32]. Therefore, cardiac ECM 
is a vital component of LV remodeling.   
Collagen III levels are elevated 3 days post-MI in rat. The increase in collagen III is followed by 
an increase in collagen I production to increase the tensile strength of the infarct tissue [33]. 
The major source of collagen in the heart is the fibroblast. In addition, post-MI fibroblasts 
expressing collagen mRNA are always co-localized with lymphocytes and macrophages in 
rats [34, 35], implicating inflammation as a necessary component of the fibrotic response. 
Fibroblasts in the post-MI LV are primarily myofibroblasts that have differentiated from 
resident fibroblasts or from infiltrating fibrocytes.  Whether the source (resident or 
infiltrating) yields myofibroblasts with different characteristics has not been examined. 
Multiple MMPs and tissue inhibitors of metalloproteinases (TIMPs) have been shown to be 
altered post-MI in both human and animal studies.  MMPs -1, -2, -3, -7, -8, -9, -12, -13, -14 
and TIMPs -1 and -2 levels increase, while TIMP-3 and TIMP-4 levels decrease post-MI [36-
38]. Specifically, MMP-9 levels are elevated from days 1-3, decrease after day 3 while still 
holding high levels at day 7 [39-41]. MMP-3 is one of the key factors related to MMP-9 
activation. MMP-3 expression is up-regulated 2 days post-MI, reaches the maximum at 4 
days and remains up regulated throughout the 14-day  [42]. 
 
Developing a Multi-scale Mathematical Model of LV Remodeling 
Temporal profiles of cellular function and ECM changes reveal that dynamic interactions 
during LV remodeling process involve cardiac function, cellular function, protein 
expression, and gene expression. Accordingly, a full spectrum of the LV remodeling may 
only be obtained by integrative knowledge on genes, protease, cells, tissue and the whole 
organ.   
A pyramid modeling structure is shown in Figure 1 to illustrate the possible layers of a 
complete model of the heart. The top layer includes LV changes in structure, function, and 
geometry, which can be regulated by the 2nd layer components including mechanical, 
electrical, chemical signals, and surgery/wound exercise. Components in the 2nd layer can 
be further related with tissue components and cellular functions regulated by biochemical 
molecules and genes in the 3rd layer. Mathematical modeling focusing on the upper layer of 
the pyramid are simplified composite models to characterize the system features, while the 
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three leukocyte cell types, the lymphocyte is the least understood in terms of post-MI 
responses. 
 
Formation of granulation tissue phase: fibroblasts 
Two to 3 days post-MI, the granulation tissue begins to form around the border of the 
infarct region.  This tissue is rich in inflammatory cells, fibroblasts, and blood vessels.[16]  
During this phase, fibroblasts start ECM deposition, which increases the myocardial tensile 
strength. Myofibroblasts first appear in the infarct at day 3 and remain at high levels 
through day 28 post-MI. The major source of fibroblasts is the resident cell [23] and the 
circulating fibrocyte  is a minor source. Previous study has shown that proliferation rate of 
fibroblasts in C57BL/6J mice was 15.4±1.1% 4 days post-MI, declined to 4.1±0.6% by 1 week, 
progressively slowed to 0.2±0.6% after 2 weeks, and 0.03±0.1% after 4 weeks [24]. Our lab 
also demonstrated that fibroblast proliferation rates decrease by day 28 post-MI, indicating 
that fibroblast densities may reach a saturation point. It has also been shown that 
myofibroblasts replicated at the border of the infarct zone migratE inward at day 4, more 
centrally at one week, sporadically at 2 weeks, and ceased by 4 weeks [24, 25]. In addition, 
our previous studies have shown that fibroblast growth rate, secretion rate, and migration 
are modulated by TGF-.   
 
Remodeling phase: myofibroblasts 
Approaching 3 weeks post-MI, the cell number in the granulation tissue starts to decrease.  
This is the first hallmark of the remodeling phase of infarct wound healing.  Apoptosis plays 
an important role in the decreasing cell numbers.  However, a unique feature of the cardiac 
scar, compared with skin scars, is the persistent presence of fibroblasts.  Fibroblasts have 
been visualized in human post-MI scars as late as 17 years after the MI.  This implies that 
fibroblasts in the cardiac scar are crucial mediators of remodeling and may be less prone to 
apoptosis than in other types of scars.   
 
 
Angiogenesis:  endothelial cells  
Angiogenesis is the process of generating new capillary blood vessels, which restores blood 
supply to the heart.  The angiogenesis phase overlaps with the inflammatory and 
granulation tissue phases, and improves cell survival during these phases. Activation and 
proliferation of endothelial cells are essential steps in angiogenesis. It has been shown that 
continuous endothelial cell activation increases angiogenesis [26]. Virag and colleagues have 
shown that proliferation rates of endothelial cell in C57BL/6J mice are 2.9±0.5% at 4 days 
post-MI, decline to 0.7±0.1% by 1 week, and remain at low levels of 0.2±0.1% after 2 weeks 
and 0.4±0.3% after 4 weeks [24]. Endothelial cells, therefore, are important contributors to 
post-MI remodeling.   
 
3.2 Cytokine and Growth Factor changes post-MI 
Multiple cytokines have been measured at the gene and protein levels.  IL-1 levels increase 
within 3 hours, remain high at 6-12 hours, and decrease by 24 hours post-MI in C57/BL6J 
mice [27]. TNF- levels are elevated on days 1 and 2, significantly decline by day 7, and 
gradually decrease to baseline levels by day 28. IL-6 shares a similar temporal profile with 
TNF- [28]. IL-10 is elevated on day 1, peaks on day 2 and shows sustained increases at day 
7, and declines significantly on day 28. TGF-1 mRNA expression significantly increases at 
day 3 and gradually decreases from days 7 to 28, even though their expression levels are still 
higher than controls [29]. In addition, Schnoor and colleagues have recently demonstrated 
that macrophages contain mRNAs for a large number of collagens (particularly collagen VI) 
and fibronectin [30]. 
 
3.3 ECM changes 
The cardiac extracellular matrix (ECM) provides the environment for cell migration, 
proliferation, adhesion, and cell-to-cell signaling. Cardiac ECM includes collagens (types I, III, 
IV, V, and VI); matricellular proteins (tenascins, thrombospondins, and secreted protein acidic 
and rich in cysteine); proteoglycans (lumican, versican, and biglycan); glycosaminoglycans 
(hyaluronic acid and dermatan sulfate); and glycoproteins (fibronectin, laminins, periostin, 
fibromodulin, and vitronectin) [31].  Extracellular proteases include serine proteases and 
MMPs that are present either bound to the ECM, in various cell types, or in circulating blood. 
In addition, the development of LV remodeling has been linked to the discontinuity and 
disruption of the supporting collagen network within in the ECM [32]. Therefore, cardiac ECM 
is a vital component of LV remodeling.   
Collagen III levels are elevated 3 days post-MI in rat. The increase in collagen III is followed by 
an increase in collagen I production to increase the tensile strength of the infarct tissue [33]. 
The major source of collagen in the heart is the fibroblast. In addition, post-MI fibroblasts 
expressing collagen mRNA are always co-localized with lymphocytes and macrophages in 
rats [34, 35], implicating inflammation as a necessary component of the fibrotic response. 
Fibroblasts in the post-MI LV are primarily myofibroblasts that have differentiated from 
resident fibroblasts or from infiltrating fibrocytes.  Whether the source (resident or 
infiltrating) yields myofibroblasts with different characteristics has not been examined. 
Multiple MMPs and tissue inhibitors of metalloproteinases (TIMPs) have been shown to be 
altered post-MI in both human and animal studies.  MMPs -1, -2, -3, -7, -8, -9, -12, -13, -14 
and TIMPs -1 and -2 levels increase, while TIMP-3 and TIMP-4 levels decrease post-MI [36-
38]. Specifically, MMP-9 levels are elevated from days 1-3, decrease after day 3 while still 
holding high levels at day 7 [39-41]. MMP-3 is one of the key factors related to MMP-9 
activation. MMP-3 expression is up-regulated 2 days post-MI, reaches the maximum at 4 
days and remains up regulated throughout the 14-day  [42]. 
 
Developing a Multi-scale Mathematical Model of LV Remodeling 
Temporal profiles of cellular function and ECM changes reveal that dynamic interactions 
during LV remodeling process involve cardiac function, cellular function, protein 
expression, and gene expression. Accordingly, a full spectrum of the LV remodeling may 
only be obtained by integrative knowledge on genes, protease, cells, tissue and the whole 
organ.   
A pyramid modeling structure is shown in Figure 1 to illustrate the possible layers of a 
complete model of the heart. The top layer includes LV changes in structure, function, and 
geometry, which can be regulated by the 2nd layer components including mechanical, 
electrical, chemical signals, and surgery/wound exercise. Components in the 2nd layer can 
be further related with tissue components and cellular functions regulated by biochemical 
molecules and genes in the 3rd layer. Mathematical modeling focusing on the upper layer of 
the pyramid are simplified composite models to characterize the system features, while the 
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under lying modular models are complicate, but capable of providing more detailed 
predictions. However, there is always a tradeoff between model simplicity and adaptability 
of the mathematical model.   
Most of the current models for the heart are structural models or cellular models, due to the 
richness of related experimental data. Previous studies have reported structural model 
focusing on mechanical properties [43, 44] and cellular model focusing on electrophysiology 
[45-49]. Our team has recently developed the first model for scar formation post-MI, which 
demonstrated the interactions among macrophage, fibroblasts, MMP-9, TGF-1 and 
collagen.  
For a cellular model built on properties of proteins, it is possible for the model to reach 
down to genetic level by reconstructing the effects of particular mutations. Examples using 
Markov models of cardiac sodium channel have been studied by Rudy and colleagues [50]. 
In addition, the cellular model can also reach up to a whole organ model including both the 
electrical and mechanical behaviors of heart [51, 52]. We predict that incorporation of 
molecular/genetic models, cellular models and structural/functional models will be one of 
the most exciting prospects of computational biology in the coming years.  
 
4. Modeling Methodology 
Various modeling techniques, such as nonlinear dynamics, physical chemistry, and 
stoichiometric network analysis have been applied to describe the underlying framework of 
biological systems [53]. Dependent on the attempting problem, different modeling methods 
can be taken to describe the system. 
Ordinary differential equations (ODE) methods have been used to represent continuous, 
deterministic systems for temporal mechanics. ODE modeling takes a population view of a 
system rather than modeling the stochastic behavior of individual proteins or molecules. 
The variables of the ODEs generally represent average concentrations of the components. 
Partial differential equations (PDEs) are the spatial counterpart of ODE and have been 
widely used to model spatially restricted reactions in a system, taking into account diffusion 
processes in the chemical reactions.  
ODE and PDE models have strength on elucidating the quantitative spatial and temporal 
interactions in the system. ODE/PDE models also integrate nonlinearity terms easily, 
matching with the embedded nonlinearity of the biological system. In addition, control 
design, stability and sensitivity analysis techniques of ODE based model have been well 
developed, which make the ODE based model an excellent tool to analyze and predict the 
effects of interventions beyond the range of available data. Our team and other researchers 
have analyzed stability of ODE based model [54, 55]. Parameter sensitivity analysis has been 
presented by Marino and colleagues [56]. Given a system dynamics 
 with parameters  and variables 
 Sensitivity of parameter  is defined as . A negative  means increasing 
parameter  will decrease the value of function F at this specific point;  a positive means 
increasing parameter  will increasing the value of function F. The maximum absolute 
value of the sensitivity function tells us which parameter affects the system dynamics most.  
However, ODE methods require exact knowledge of reaction rate and concentrations of the 
biochemical factors, which is hard to acquire in some biological systems. In case of the non-
precise measurement of the parameters, parameter sensitivity analysis is generally desired 
for system performance and validation of the parameters calls for parameter search in a 
given space to optimize the fitting between computational predictions and experimental 
data.  
Non-ODE methods have also been widely applied to model biological systems where the 
actions of individual elements of a system, rather than the population behavior, is of interest 
[57].  Stochastic methods have been applied to model the individual behavior of molecules 
and represent variability in the overall behavior of a system [58]. Stochastic method has the 
advantages on handling imprecise data, where concentrations of molecules are represented 
by relative levels rather than exact values in ODE methods.   
Agent-based modeling method has also been developed based on the rules and mechanisms 
of behavior of individual component of a system [59]. Agents represent the system 
components which share the same mechanism identified by experimental results. The 
mechanisms are expressed as a series of conditional (if-then) statements and computer 
programs are written to describe the rules of behavior. Agent-based methods provide an 
easy way to translate basic Scientific data to model. However, it requires extensive 
computational power to simulate large numbers of agents of a real system. In addition, 
agent-based model is very difficult to validate and calibrate with experimental data.  
There are also other model methods, such as Petri nets, process algebra (PEPA) and SBML-
based graphical model, but ODE/PDE model, stochastic model, and agent-based model are 
the most commonly applied techniques. The strength and weakness of the aforementioned 
modeling methods are summarized in Table 1. 
 
5. Mathematical Modeling Procedure 
A well established mathematical model is easy to understand, reproduce, and test. A 
modeling standard for reproducibility has been presented by Dr. Bassingwaite [60]. A 
recommended modeling procedure is summarized as following steps.  
1) Identify the functionality of the model. A modeler has to determine the scope of the 
model and make realistic assumptions to develop the model at this step.  
2) Determine the structure and content of the model. A modeler will identify variables of the 
ODE/stochastic model (concentrations, mass, etc) or agents for the agent-based model, units 
of the variables, parameters of the model (reaction rate, growth rate), inputs/outputs (ODE 
model), or nodes/edges (stochastic model).   
3) Quantify the mathematical relation based on physical chemistry laws, mass balance, 
charge balance, energy balance for ODE model, evolutionary probability for stochastic 
model, and behavior rules for agent-based model. For example, the mass balance equation 
for a compartmental modeling can be written as 
Mass change = Sources – Sinks.  
4) Verify the mathematical relation based on unitary balance of equations, variables and 
parameters.  
5) Develop software to compute the mathematical model and compare the numerical 
solution with available analytical solution. 
6) Validate the mathematical model. 
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under lying modular models are complicate, but capable of providing more detailed 
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programs are written to describe the rules of behavior. Agent-based methods provide an 
easy way to translate basic Scientific data to model. However, it requires extensive 
computational power to simulate large numbers of agents of a real system. In addition, 
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There are also other model methods, such as Petri nets, process algebra (PEPA) and SBML-
based graphical model, but ODE/PDE model, stochastic model, and agent-based model are 
the most commonly applied techniques. The strength and weakness of the aforementioned 
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model, and behavior rules for agent-based model. For example, the mass balance equation 
for a compartmental modeling can be written as 
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parameters.  
5) Develop software to compute the mathematical model and compare the numerical 
solution with available analytical solution. 
6) Validate the mathematical model. 
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5.1 Validation of the Mathematical model 
The crucial component of a model is the ability of the model to accurately reflect the real-
world process being modeled. Validation of the model, therefore, is a necessary step to 
evaluate the similarity.   Validation of mathematical model focuses on two aspects: 1) 
assumptions made during the model development, and 2) behavior of the model. Validation 
of an assumption can be addressed by explicit statement of conditions and rules to 
implement the model.  All models represent some degree of abstraction of the system, 
assumptions of the model determines the degree of abstraction. Therefore, clarity of the 
assumptions is the key for model validation. 
Behavior of the model can be validated by comparing the behavior of the model with real-
world experimental data. When the behavior of the model matches with the experimental 
data, the model is validated for the particular case. Mismatch of the model behavior and 
experimental data requires further investigation on either model structure or parameters 
calibration.  
Practically, validation of the mathematical model includes the following aspects. 1) Confirm 
that defined initial and boundary conditions (generally based on the assumptions) are 
appropriate to the physiology and physical chemistry data. 2) Compare computational and 
experimental results to see if the two sets of values are compatible.  This comparison is 
made by determining the fitting error between the computational and experimental results. 
3) Optimize and document parameters with respect to the fitting errors. 4) Test predictions 
of the model with new experiments. 
A good model will satisfy a desired fitting of experimental results. If the lack of fitting is 
caused by structural defects, a more extensive literature search is needed to find the missing 
regulatory mechanisms. To minimize the fitting error caused by parameter calibration, 
parameter optimization is needed to minimize the fitting error. The most commonly applied 
technique is least squared based optimization which minimize the value of , where 
 is the fitting error at ith fitting point and N denotes the total fitting points. Thus, a 
desirable parameter setting of the model will be obtained with respect to a given fitting 
error. 
 
6. Conclusion 
 
In summary, progressive LV remodeling following MI involves spatiotemporal profiles of 
cellular, protein, and genetic components. Although this review focuses on the modeling of 
LV remodeling post-MI, it is worth mentioning that modeling techniques have been widely 
applied to other gene regulatory networks, metabolic pathways, cells, and organs [49, 61-
66]. However, integration of multi-scale mathematical models into the whole organ model 
still needs intensive investigation. It is anticipated that integrated computational and 
experimental approaches will greatly facilitate researchers in their everyday experimental 
work and shed insight on regulatory mechanisms of LV remodeling as well as other disease 
processes. 
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Figure Legends 
Figure 1. Pyramid structure of LV remodeling post-MI. Progressive LV remodeling includes 
tissue components, cell functions, protein interactions and gene regulation. A multi-scale 
mathematical model should weave the components into a model for the whole system. 
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Table Legends 
Table 1. Summary of the strengths and weaknesses of different mathematical methods. 
 
 
 
Modeling Technique Strengths Weaknesses 
Ordinary/partial 
differential equation  
model 
Continuous and deterministic model for 
exact values with biophysical meaning 
Characterizes temporal and spatial 
interactions 
Well developed stability analysis techniques 
Provides good prediction on unmeasured 
data 
Requires exact knowledge  
of the system and precise 
measurement of the 
parameters 
Stochastic model Probability based model 
Robust to imprecise parameters 
Provides relative levels 
instead of exact values 
Agent-based model Easy to translate from experimental 
knowledge to system behavior 
High requirement on 
computational power 
Hard to validate the model 
and calibrate parameters 
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